- Home
- MEDP vs CELH Comparison
MEDP vs CELH Comparison
Compare MEDP & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MEDP | CELH |
|---|---|---|
| Founded | 1992 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.5B |
| IPO Year | 2016 | 2008 |
Fundamental Metrics
Financial Performance| Metric | MEDP | CELH |
|---|---|---|
| Price | $471.64 | $43.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $498.25 | $66.50 |
| AVG Volume (30 Days) | 435.8K | ★ 5.3M |
| Earning Date | 05-12-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.98 | N/A |
| EPS | ★ 15.28 | 0.25 |
| Revenue | N/A | ★ $1,318,014,000.00 |
| Revenue This Year | $13.11 | $35.89 |
| Revenue Next Year | $7.51 | $11.06 |
| P/E Ratio | ★ $30.76 | $175.34 |
| Revenue Growth | N/A | ★ 101.65 |
| 52 Week Low | $250.05 | $26.09 |
| 52 Week High | $628.92 | $66.74 |
Technical Indicators
Market Signals| Indicator | MEDP | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 37.05 |
| Support Level | $457.41 | $40.90 |
| Resistance Level | $501.30 | $47.24 |
| Average True Range (ATR) | 17.34 | 2.46 |
| MACD | 7.68 | -0.50 |
| Stochastic Oscillator | 87.87 | 6.90 |
Price Performance
Historical ComparisonAbout MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.